Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Current and emerging therapies in multiple sclerosis: a systematic review.
Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
Case report: an orofacial pain patient with spots on the brain-multiple sclerosis versus central systemic lupus erythematosus.
TCR Bias and HLA Cross-Restriction Are Strategies of Human Brain-Infiltrating JC Virus-Specific CD4+ T Cells during Viral Infection.
SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease.
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
Infectious mononucleosis.
Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis.
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Progress of mesenchymal stem cell therapy for neural and retinal diseases.
Risk of relapse phenotype recurrence in multiple sclerosis.
Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
Recurrent Varicella following Steroids and Fingolimod in a Multiple Sclerosis Patient.
Combination of robot-assisted and conventional body-weight-supported treadmill training improves gait in persons with multiple sclerosis: a pilot study.
Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life.
Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis.
The myelin mutants as models to study myelin repair in the leukodystrophies.
Effect of short-term interferon-β treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23.
Multiple sclerosis: TNF receptor 1 gene variant could explain failure of TNF-blocking drugs in multiple sclerosis.
Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccine.
Optic Neuritis, its Differential Diagnosis and Management.
Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.
Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.
Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE).
Pages
« first
‹ previous
…
309
310
311
312
313
314
315
316
317
…
next ›
last »